Market Cap : 6.88 M | Enterprise Value : 6.75 M | P/E (TTM) : | P/B : |
---|
OTCPK:ICOTF has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OTCPK:ICOTF has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.
iCo Therapeutics's cash flow from discontinued operations for the three months ended in Sep. 2020 was $0.00 Mil. It means iCo Therapeutics received $0.00 Mil from the sale of part of business quarterly. iCo Therapeutics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Cash received by a company that comes from the sale of part of business.
Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2020 was 0 (Dec. 2019 ) + 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) = $0.00 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline